With a revenue increase of 34.08% in the third quarter 2026, year on year to cumulative value of $263 million, Establishment Labs Holdings Inc 's revenue per employee grew on a trailing twelve months basis to $ 262,353. The productivity of Establishment Labs Holdings Inc 's employees was 0.0%, above the company average. Within the Healthcare sector Employees of 369 other companies have achieved higher revenue per employee. While Establishment Labs Holdings Inc 's total ranking has deteriorated compared to the previous quarter from 2238 to 2826. Establishment Labs Holdings Inc has 1,004 employees.
In a remarkable milestone for women’s health and aesthetics, Establishment Labs Holdings Inc. (NASDAQ: ESTA) has announced that the first U.S. patients have successfully received breast augmentations using the newly FDA-approved Motiva Implants. This significant achievement brings cutting-edge technology to the forefront of cosmetic and reconstructive procedures, marking a new era in patient care and satisfaction.The recent FDA approval of Motiva Implants is not just a regulatory victory; it signifies a paradigm shift in the approach to breast augmentation. These implants are designed with advanced technology that prioritizes patient safety and outcomes. Unlike traditional implants, Motiva Implants leverage a unique NanoTexture surface and an innovative ergonomic shape that allows for more natural results and potentially fewer complications.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
